Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

DOI: https://doi.org/10.1177/17588359241290373

2024-10-21

Abstract:[This corrects the article DOI: 10.1177/17588359241267148.].

What problem does this paper attempt to address?

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou,Mahboubeh Yazdanifar,Lopamudra Das Roy,Lynsey M. Whilding,Artemis Gavrill,John Maher,Pinku Mukherjee

DOI: https://doi.org/10.3389/fimmu.2020.628776

IF: 7.3

2020-12-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.01149.].

immunology
Correction to: Biomarkers in clinical epidemiology studies

DOI: https://doi.org/10.1093/ckj/sfae293

2024-09-28

Abstract:[This corrects the article DOI: 10.1093/ckj/sfae130.].
Erratum to "BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells"

Bin Ma,Wenjia Guo,Meihui Shan,Nan Zhang,Binlin Ma,Gang Sun

DOI: https://doi.org/10.1515/biol-2022-0810

2023-12-16

Abstract:[This corrects the article DOI: 10.1515/biol-2020-0054.].
Erratum to "Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment"

Hongye He,Feng Li,Rui Tang,Nianhong Wu,Ying Zhou,Yuting Cao,Can Wang,Li Wan,Yang Zhou,Hua Zhuang,Pan Li

DOI: https://doi.org/10.34133/bmr.0088

2024-10-07

Abstract:[This corrects the article DOI: 10.34133/bmr.0064.].
Corrigendum to "Long recurrence-free survival of localized rectal melanoma after abdominoperineal resection in comparison to partial excision and highlighting the place of immunotherapy: A case report."

DOI: https://doi.org/10.1177/20542704241260192

2024-06-02

JRSM Open

Abstract:[This corrects the article DOI: 10.1177/20542704221148059.].
Corrigendum to "the Role of 18F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis".

Qiufang Liu,Chen Wang,Panli Li,Jianjun Liu,Gang Huang,Shaoli Song

DOI: https://doi.org/10.1155/2016/1235429

2016-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2016/3746232.].
Erratum: "Toward improved models of human cancer" [APL Bioeng. 5, 010901 (2021)]

Bryan E Welm,Christos Vaklavas,Alana L Welm

DOI: https://doi.org/10.1063/5.0057199

2021-06-02

Abstract:[This corrects the article DOI: 10.1063/5.0030534.].
Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Frontiers Production Office

DOI: https://doi.org/10.3389/fphar.2022.1092147

IF: 5.6

2022-11-22

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.973448.].

pharmacology & pharmacy
Erratum to "Bifunctional Tumor-Targeted Bioprobe for Phototheranosis"

Hae Sang Park,Shinya Yokomizo,Haoran Wang,Sophia Manganiello,Hailey Monaco,Rose McDonnell,Hajin Joanne Kim,Jiyun Rho,Sung Ahn,Jason Gladstone,Harry Jung,Homan Kang,Kai Bao,Satoshi Kashiwagi,Hak Soo Choi

DOI: https://doi.org/10.34133/bmr.0036

2024-05-29

Abstract:[This corrects the article DOI: 10.34133/bmr.0002.].
Erratum: Transcriptional Downregulation of Mir-4306 Serves As a New Therapeutic Target for Triple Negative Breast Cancer: Erratum.

Zitong Zhao,Lin Li,Peina Du,Liying Ma,Weimin Zhang,Leilei Zheng,Bo Lan,Bailin Zhang,Fei Ma,Bo Xu,Qimin Zhan,Yongmei Song

DOI: https://doi.org/10.7150/thno.82636

IF: 11.6

2023-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.30701.].
Erratum to: Detection of a novel mutation in exon 20 of the BRCA1 gene

Abhijit Chakraborty,Atul Katarkar,Keya Chaudhuri,Ashis Mukhopadhyay,Jayasri Basak

DOI: https://doi.org/10.2478/s11658-014-0184-6

2014-03-15

Abstract:[This corrects the article DOI: 10.2478/s11658-013-0110-3.].
Erratum to "From goal to outcome: Analyzing the progression of biomedical sciences PhD careers in a longitudinal study using an expanded taxonomy"

DOI: https://doi.org/10.1096/fba.2023-00134

2023-12-01

Abstract:[This corrects the article DOI: 10.1096/fba.2023-00072.].
Erratum: Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]

DOI: https://doi.org/10.2147/JHC.S467902

2024-03-14

Abstract:[This corrects the article DOI: 10.2147/JHC.S444530.].
Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]

DOI: https://doi.org/10.2147/IJN.S500182

2024-10-14

Abstract:[This corrects the article DOI: 10.2147/IJN.S448556.].
Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2023.1281693

2023-09-27

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1169537.].
Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

Hongzhi Li,Weihua Yuan,Shufang Bin,Guang Wu,Panyuan Li,Min Liu,Jifeng Yang,Xiang Li,Kaiyan Yang,Haihua Gu

2022-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 688 in vol. 10, PMID: 32195036.].
Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Jun Cao,Mengdi Zhang,Bin Wang,Long Zhang,Fangfang Zhou,Meiyu Fang

DOI: https://doi.org/10.3389/fonc.2021.745052

IF: 4.7

2021-08-17

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.658552.].

oncology
Erratum: Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2024.1414294

IF: 4.7

2024-04-20

Frontiers in Oncology

Abstract:This article is an erratum on: Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer

oncology
Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Wan Li,Liwen Ren,Xiangjin Zheng,Jinyi Liu,Jinhua Wang,Tengfei Ji,Guanhua Du

DOI: https://doi.org/10.1016/j.apsb.2024.04.025

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2019.12.012.].
Erratum: Mesenchymal Stem Cell-Based NK4 Gene Therapy in Nude Mice Bearing Gastric Cancer Xenografts [Corrigendum]

DOI: https://doi.org/10.2147/DDDT.S493671

2024-10-07

Abstract:[This corrects the article DOI: 10.2147/DDDT.S71466.].

Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Correction to: Biomarkers in clinical epidemiology studies

Erratum to "BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells"

Erratum to "Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment"

Corrigendum to "Long recurrence-free survival of localized rectal melanoma after abdominoperineal resection in comparison to partial excision and highlighting the place of immunotherapy: A case report."

Corrigendum to "the Role of 18F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis".

Erratum: "Toward improved models of human cancer" [APL Bioeng. 5, 010901 (2021)]

Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Erratum to "Bifunctional Tumor-Targeted Bioprobe for Phototheranosis"

Erratum: Transcriptional Downregulation of Mir-4306 Serves As a New Therapeutic Target for Triple Negative Breast Cancer: Erratum.

Erratum to: Detection of a novel mutation in exon 20 of the BRCA1 gene

Erratum to "From goal to outcome: Analyzing the progression of biomedical sciences PhD careers in a longitudinal study using an expanded taxonomy"

Erratum: Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]

Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]

Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Erratum: Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer

Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Erratum: Mesenchymal Stem Cell-Based NK4 Gene Therapy in Nude Mice Bearing Gastric Cancer Xenografts [Corrigendum]